Clinical Trial Update: Dabigatran Versus Apixaban in Cerebral Venous Thrombosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is comparing dabigatran and apixaban in cerebral venous sinus thrombosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Sinus Thrombosis

Drugs mentioned

• Apixaban (apixaban)
• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Cerebral Venous Sinus Thrombosis | Phase 3 | Status: RECRUITING